| 1 |
李喆，莫琳芳，任成山. 支气管哮喘药物治疗现状及进展[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(5): 571-573.
|
| 2 |
Kumar P, Singh G, Goyal JP, et al. Association of common comorbidities with asthma in children: a cross-sectional study[J]. Sudan J Paediatr, 2019, 19(2): 88-92.
|
| 3 |
魏勇. 小儿支气管哮喘细胞免疫失衡的研究进展[J]. 中国妇幼保健，2019, 34(14): 3375-3378.
|
| 4 |
谭燕萍，李景新，欧晓华，等. 益生菌联合孟鲁司特钠咀嚼片对支气管哮喘伴变应性鼻炎患儿外周血Th17/Treg免疫平衡的影响[J]. 中国药业，2019, 28(15): 64-67.
|
| 5 |
中华医学会儿科学分会呼吸学组. 儿童支气管哮喘诊断与防治指南[J]. 中华儿科杂志，2008, 46(10): 745.
|
| 6 |
Vogelberg C, Goldstein S, Graham L, et al. A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma [J]. Respir Res, 2020, 21(1): 19.
|
| 7 |
陈其芬，张亦维. 布拉氏酵母菌散剂联合阿奇霉素序贯治疗肺炎支原体肺炎继发腹泻患儿的临床研究[J]. 中国当代儿科杂志，2018, 20(2): 116-120.
|
| 8 |
方国兴，胡国华. 维生素D联合布拉氏酵母菌治疗小儿反复呼吸道感染的临床疗效研究[J]. 中国全科医学，2017, 20(34): 4284-4288.
|
| 9 |
张佩红，陈啸洪，陈冰蓉，等. 哮喘儿童血清细胞因子水平及布拉氏酵母菌干预的研究[J]. 中国临床药理学与治疗学，2017, 22(3): 332-336.
|
| 10 |
McGeachie MJ, Sordillo JE, Dahlin A, et al. Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy[J]. Respir Res, 2020, 21(1): 31.
|
| 11 |
Castro LL, Kitoko JZ, Xisto DG, et al. Multiple doses of adipose tissue-derived mesenchymal stromal cells induce immunosuppression in experimental asthma[J]. Stem Cells Transl Med, 2020, 9(2): 250-260.
|
| 12 |
Zhang Y, Wang H. Efficacy of montelukast sodium chewable tablets combined with inhaled budesonide in treating pediatric asthma and its effect on inflammatory factors[J]. Pharmazie, 2019, 74(11): 694-697.
|
| 13 |
Lin SC, Liou YM, Ling TY, et al. Placenta-derived mesenchymal stem cells reduce the interleukin-5 level experimentally in Children with asthma[J]. Int J Med Sci, 2019, 16(11): 1430-1438.
|
| 14 |
Liu Z, Niu C, Ying L, et al. Exploration of the serum interleukin-17 and interleukin-27 expression levels in Children with bronchial asthma and their correlation with indicators of Lung Function[J]. Genet Test Mol Biomarkers, 2020, 24(1): 10-16.
|
| 15 |
Hanashiro J, Muraosa Y, Toyotome T, et al. Schizophyllum commune induces IL-17-mediated neutrophilic airway inflammation in OVA-induced asthma model mice[J]. Sci Rep, 2019, 9(1): 19321.
|
| 16 |
Wardzyńska A, Pawełczyk M, Rywaniak J, et al. Circulating microRNAs and T-cell cytokine expression are associated with the characteristics of asthma exacerbation[J]. Allergy Asthma Immunol Res, 2020, 12(1): 125-136.
|
| 17 |
Ito T, Hirose K, Nakajima H. IL-22 in bronchial asthma[J]. Arerugi, 2019, 68(8): 923-927.
|
| 18 |
Mansour AI, Abd Almonaem ER, Behairy OG, et al. Predictive value of IL-35 and IL-17 in diagnosis of childhood asthma[J]. Scand J Clin Lab Invest, 2017, 77(5): 373-378.
|
| 19 |
王才木，陈启江，崔巍，等. 血清S100β蛋白、神经元特异性烯醇化酶和球静脉氧饱和度在老年心肺脑复苏患者亚低温治疗中变化及其对预后的影响[J]. 中国老年学杂志，2018, 38(10): 2325-2327.
|
| 20 |
庞文箫，易冬玲，张朝勇，等. 重症手足口病患儿外周血炎性因子、神经元特异性烯醇化酶与中枢神经特异性S100β蛋白水平变化[J/CD]. 中华实验和临床感染病杂志(电子版), 2019, 13(3): 250-254.
|
| 21 |
Qu D, Ling Z, Tan X, et al. High mobility group protein B1 (HMGB1) interacts with receptor for advanced glycation end products (RAGE) to promote airway smooth muscle cell proliferation through ERK and NF-κB pathways[J]. Int J Clin Exp Pathol, 2019, 12(9): 3268-3278.
|
| 22 |
Hwang YH, Lee Y, Paik MJ, et al. Inhibitions of HMGB1 and TLR4 alleviate DINP-induced asthma in mice[J]. Toxicol Res (Camb), 2019, 8(5): 621-629.
|
| 23 |
沈梦晴，吴婷，王菲. 布地奈德联合特异性免疫治疗对支气管哮喘患儿1，25-二羟维生素D3及IL-6、IL-10水平的影响[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(1): 43-47.
|